Neuvasq
3 known investors
Find your way into Neuvasq
1,021 people in our graph share verified history with the Neuvasq team — schools, employers, funds. One of them is your warm intro.
Laura Buhlerunlockedknows Denis Bedoret · together at McKinsey & Company (overlapped)
×7knows the team · via McKinsey & Company
knows the team · via Université libre de Bruxelles
×3knows the team · via Children's Hospital Boston
Neuvasq Biotechnologies is a biotech spin-off from the Université libre de Bruxelles developing therapies that target the Gpr124/Reck signaling complex to repair the blood-brain and blood-CNS barriers in neurological and cerebrovascular disorders. The company translates research on brain vasculature and the blood-brain barrier into drug development programs.
Founders & leadership
BV
Benoit VanhollebekeinScientific FounderBenoit Vanhollebeke is a molecular biologist at Université libre de Bruxelles whose research focuses on neurovascular development and blood-brain barrier mechanisms; he founded Neuvasq Biotechnologies to translate this research into therapeutics targeting the blood-brain barrier for neurological disorders.
DB
Denis BedoretinExecutive DirectorDenis Bedoret held CEO roles at a contract development and manufacturing organization focused on cell and gene therapy, and led operations at a contract research organization. He also worked in management consulting on strategy and operations, conducted medical research at academic institutions, and has experience across biopharmaceuticals, healthcare, chemicals, and other sectors.
Investors · 3
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AJun 2021Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Neuvasq do?
- Neuvasq Biotechnologies is a biotech spin-off from the Université libre de Bruxelles developing therapies that target the Gpr124/Reck signaling complex to repair the blood-brain and blood-CNS barriers in neurological and cerebrovascular disorders. The company translates research on brain vasculature and the blood-brain barrier into drug development programs.
- Who founded Neuvasq?
- Neuvasq was founded by Benoit Vanhollebeke.
- Who are Neuvasq's investors?
- Neuvasq's investors include Newton Biocapital, Sambrinvest, Wallonie Entreprendre.